Scholars Central

Conference abstract

Anti-tubercular treatment induced Exfoliative Dermatitis

Authors: Plessan Joy, Dona Sajan, Sobhana Kumari, Ramani P T, Scaria Thomas P

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Exfoliative Dermatitis is a serious, at times life-threatening, reaction pattern of the skin characterized by generalized and uniform redness and scaling involving practically the entire skin. It is usually drug induced, idiopathic, or secondary to underlying cutaneous or systemic disease. Theoretically, any drug may cause exfoliative dermatitis. Among antitubercular drugs, exfoliative dermatitis has been reported with rifampicin, isoniazid, ethambutol, pyrazinamide, streptomycin, PAS either singly or combination of two drugs in some case reports. It usually presents by six to eight weeks of initiation of antitubercular treatment. Early recognition, prompt withdrawal of antitubercular therapy and institution of steroids, if reaction is severe, are cornerstones of its management. Here we report a rare case of pulmonary tuberculosis with exfoliative dermatitis. A 70-yearold female patient was diagnosed with a case of smear positive pulmonary tuberculosis, on CAT-I antitubercular treatment for ten weeks, presented to us with complaints of pruritus and scaling all over the body. On examination, there was generalized scaling eruption distributed all over the body and face. A diagnosis of exfoliative dermatitis due to antitubercular treatment was made because she was not taking other medicines except losartan which she was taking for last 6 years. Antitubercular treatment was then withheld and she was started on corticosteroids. Further workup revealed a normal total leukocyte count, normal liver and kidney function tests. We analyzed the adverse drug event using Naranjo scale and found it to be a probable reaction with a score of 6. The event had moderate severity on the Modified Hartwig and Seigel scale.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmacovigilance
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Plessan Joy”
  • BylineArticles whose byline prints “Dona Sajan”
  • BylineArticles whose byline prints “Sobhana Kumari”
  • BylineArticles whose byline prints “Ramani P T”
  • BylineArticles whose byline prints “Scaria Thomas P”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels